- Nipple Schwannoma: A Case Report and Literature Review on Nipple Mass
-
Kang YJ, Woo OH, Kim A
- KMID: 2553579
- J Breast Cancer.
- 2024 Feb;27(1):72-77.
- doi: 10.4048/jbc.2023.0119
Schwannomas are slow-growing benign tumors originating from the Schwann cells of the peripheral nerve sheaths. Herein, we report the first documented case of a schwannoma presenting as a painful nipple... -
- CITED
-
- Close
- SHARE
-
- Close
- Racial/Ethnic Differences in Pathologic Complete Response to Neoadjuvant Chemotherapy and Survival Among Early-Stage, Erb-B2 Receptor Tyrosine Kinase 2-Low Breast Cancer Patients
-
Freeman JQ, Li JL, Omoleye OJ
- KMID: 2553577
- J Breast Cancer.
- 2024 Feb;27(1):54-60.
- doi: 10.4048/jbc.2023.0166
Racial/ethnic differences in pathologic complete response (pCR), and in overall survival (OS) by pCR status, among early-stage, erb-b2 receptor tyrosine kinase 2 (ERBB2)-low breast cancer patients after neoadjuvant chemotherapy (NACT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy With Immunotherapy Result in Different Tumor Shrinkage Patterns in TripleNegative Breast Cancer
-
Zou J, Zhang L, Chen Y, Lin Y, Cheng M, Zheng X, Zhuang X, Wang K
- KMID: 2553575
- J Breast Cancer.
- 2024 Feb;27(1):27-36.
- doi: 10.4048/jbc.2023.0136
Purpose: This study aims to explore whether neoadjuvant chemotherapy with immunotherapy (NACI) leads to different tumor shrinkage patterns, based on magnetic resonance imaging (MRI), compared to neoadjuvant chemotherapy (NAC) alone... -
- CITED
-
- Close
- SHARE
-
- Close
- Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched Cohort
-
Shin DS, Bang YJ, Choi JY, Jang SY, Lee H, Kwak Y, Chae BJ, Yu J, Lee JE, Kim SW, Nam SJ, Jeon BJ, Pyon JK, Mun GH, Lee KT, Ryu JM
- KMID: 2553573
- J Breast Cancer.
- 2024 Feb;27(1):14-26.
- doi: 10.4048/jbc.2023.0196
Purpose: Despite the increasing use of immediate breast reconstruction (IBR), its oncologic safety in the setting of neoadjuvant chemotherapy (NACT) needs to be comprehensively clarified in breast cancer management. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival Outcomes Based on Axillary Surgery in Ductal Carcinoma In Situ: A Nationwide Study From the Korean Breast Cancer Society
-
Kim BK, Woo J, Lee J, Kang E, Baek SY, Lee S, Lee HJ, Lee J, Sun WY, Korean Breast Cancer Society
- KMID: 2553574
- J Breast Cancer.
- 2024 Feb;27(1):1-13.
- doi: 10.4048/jbc.2023.0221
Purpose: In total mastectomy (TM), sentinel lymph node biopsy (SLNB) is recommended but can be omitted for breast-conserving surgery (BCS) in patients with ductal carcinoma in situ (DCIS). However, concerns... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Perturbations of Critical Cancer-regulatory Genes in TripleNegative Breast Cancer Cells Within the Humanized Microenvironment of Patient-derived Xenograft Models
-
Her Y, Yun J, Son HY, Heo W, Kim JI, Moon HG
- KMID: 2553576
- J Breast Cancer.
- 2024 Feb;27(1):37-53.
- doi: 10.4048/jbc.2023.0177
Purpose: In this study, we aimed to establish humanized patient-derived xenograft (PDX) models for triple-negative breast cancer (TNBC) using cord blood (CB) hematopoietic stem cells (HSCs). Additionally, we attempted to... -
- CITED
-
- Close
- SHARE
-
- Close
- Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial
-
Jung JJ, Cheun JH, Kim SY, Koh J, Ryu JM, Yoo TK, Shin HC, Ahn SG, Park S, Lim W, Nam SE, Park MH, Kim KS, Kang T, Lee J, Youn HJ, Kim YS, Yoon CI, Kim HK, Moon HG, Han W, Cho N, Kim MK, Lee HB
- KMID: 2553578
- J Breast Cancer.
- 2024 Feb;27(1):61-71.
- doi: 10.4048/jbc.2023.0265
Purpose: Advances in chemotherapeutic and targeted agents have increased pathologic complete response (pCR) rates after neoadjuvant systemic therapy (NST). Vacuum-assisted biopsy (VAB) has been suggested to accurately evaluate pCR. This... -
- CITED
-
- Close
- SHARE
-
- Close
